Publications (2000 - 2009)

  1. Pešić M, Podolski A, Rakić L, Ruždijić S.
    Purine analogs sensitize the multidrug resistant cell line (NCI-H460/R) to doxorubicin and stimulate the cell growth inhibitory effect of verapamil.
    Investigational New Drugs (2009), Jun 18. [Epub ahead of print],
    doi: 10.1007/s10637-009-9277-x Link

  2. Bankovic J, Stojsic J, Jovanovic D, Andjelkovic T, Milinkovic V, Ruzdijic S, Tanic N.
    Identification of genes associated with non-small cell lung cancer promotion and progression.
    Lung Cancer (2009), May 25. [Epub ahead of print]
    doi:10.1016/j.lungcan.2009.04.010 Link

  3. Pesic M, Andjelkovic T, Bankovic J, Markovic ID, Rakic L, Ruzdijic S.
    Sulfinosine enhances doxorubicin efficacy through synergism and by reversing multidrug resistance in the human non-small cell lung carcinoma cell line (NCI-H460/R).
    Investigational New Drugs (2009), 27(2):99-110. Link

  4. Andjelkovic T, Pesic M, Bankovic J, Tanic N, Markovic ID, Ruzdijic S.
    Synergistic effects of the purine analog sulfinosine and curcumin on the multidrug resistant human non-small cell lung carcinoma cell line (NCI-H460/R).
    Cancer Biology & Therapy (2008), 7(7):1024-1032 Link

  5. Markovic J, Stojsic J, Zunic S, Ruzdijic S, Tanic N.
    Genomic instability in patients with non-small cell lung cancer assessed by the arbitrarily primed polymerase chain reaction.
    Cancer Investigations (2008), 26(3):262-268. Link

  6. Jankovic D, Pesic M, Markovic J, Kanazir S, Markovic I, Rakic L, Ruzdijic S.
    The combination of sulfinosine and 8-Cl-cAMP induces synergistic cell growth inhibition of the human neuroblastoma cell line in vitro.
    Investigational New Drugs (2006), 24(1): 15-24. Link

  7. Pešić M, Marković JŽ, Janković D, Marković ID, Rakić Lj, Kanazir S, Ruždijić S.
    Induced resistance in the human non small cell lung carcinoma (NCI-H460) cell line in vitro by anticancer drugs.
    Journal of Chemotherapy (2006), 18(1): 66-73.Link

  8. Vucic V, Isenovic RE, Adzic M, Ruzdijic S, Radojcic BM.
    Effects of gamma radiation on cell growth, cell arrest, death, and superoxide dismutase expression by DU 145 human prostate cancer.
    Brazilian Journal of Medical and Biological Research (2006), 39(2): 227-236. Link

  9. Ruzdijic S, Pesic M, Kanazir S, Rakic L, Tanic N.
    The role of genetic instability in the development of the multidrug resistance phenotype in brain tumors.
    Neurobiological Studies – From Genes to Behaviour, (2006): ISBN: 81-308-0107-8 (Eds: S. Ruzdijic and Lj. Rakic) Research Signpost, Kerala, India, 1-19. Link

  10. Žunić S, Milošević J, Ruždijić S, Zunic S, Djordjevic-Denić G, Rakić L.
    Evaluation of apoptotic capacity in bronchoalveolar lavage of smokers and patients with NSCLC.
    Journal of Biological Regulators and Homeostatic Agents (2004), 18( 3-4): 372-380. Link

  11. Koricanac LB, Todorovic DV, Popovic NM, Demajo MA, Ruzdijic SD, Ristic-Fira M.
    Inhibition of B16 mouse melanoma cell growth and induction of apoptotic cell death with 8-chloroadenosine-3’,5’-monophosphate and tiazofurin.
    Annals of New York Academy of Sciences (2004), 1030:384-392. Link

  12. Stojiljkovic M, Piperski V, Dacevic D, Rakic L, Ruzdijic S, Kanazir S.
    Characterization of 9L glioma model of the Wistar rats.
    Journal of Neuro-oncology (2003), 63(1): 1-7. Link

  13. Grbovic O, Jovic V, Ruzdijic S, Pejanovic V, Rakic L, Kanazir S.
    8-Cl-cAMP affects glioma cell cycle kinetics and selectively induces apoptosis.
    Cancer Investigations (2002), 20(7-8), 972-982. Link

  14. 14. Milosevic J, Kanazir S, Medic-Mijacevic L, Pejanovic V, Stokic Z, Konjevic G, Rakic L, Ruzdijic S.
    Sulfinosine-induced cell growth inhibition and apoptosis in human lung carcinomas in vitro.
    Investigational New Drugs(2002), 20(3): 229-240. Link

  15. Ristic-Fira A, Nikolic D, Petrovic I, Ruzdijic S, Raffaele L, Sabini MG, Cirrone, G. Cuttone GAP, Farruggia G, Masotti L, Kanazir DT.
    The late effects of proton irradiation on cell growth, cell cycle arrest and apoptosis in a human melanoma cell line.
    Journal of Experimental Clinical Cancer Research (2001), 20(1): 135- 143. Link

  16. Pesic M., Drabek K, Esler C, Ruzdijic S, Pejanovic V, Pietrzkowski Z.
    Inhibition of cells growth and proliferation in human glioma cells and normal astrocytes induced by 8-Cl-cAMP and tiazofurin.
    Nucleoside, Nucleotide & Nucleic Acids (2000), 19(5-6): 963-975. Link

  17. Drabek K, Pesic M, Piperski V, Ruzdijic S, Medic-Mijacevic L, Pietrzkowski Z, Rakic L.
    8-Cl-cAMP and tiazofurin affect VEGF production and GFAP expression in human glioblastoma cells.
    Anti-Cancer Drugs (2000), 11(9): 765-770. Link

  18. Ruzdijic S, Pietrzkowski Z, Cieslak D.
    Control of CD44 gene expression for therapeutic use.
    Official Gazette of the United States of Patent and Trademark Office Patents, (1999) vol 1228, issue 4, pp 1-44, 1999. U.S.A. Patent 5,990,29 Link